Archive · 3 Dec 2025
Healthify targets US market for growth
Healthify is an Indian company that helps people track their diet and stay healthy.
They are now focusing more on the US market because they think it will bring in a lot of money.
Right now, they make about $2 million every year, but they want to make much more by next year and even more by 2027.
They plan to work with insurance companies and dieticians in the US to help people pay for their services.
In India, they are working with drug companies to help people manage their weight.
Healthify wants to be profitable soon and plans to go public in a few years.
Healthify is focusing on the US market to become its primary revenue source by 2027.
The company aims to increase its annual recurring revenue from $2 million to double-digit millions in the US by next year.
Healthify plans to partner with insurance providers and registered dieticians in the US to facilitate reimbursement for services.
In India, Healthify is collaborating with pharmaceutical companies, particularly in the anti-obesity drug segment.
Healthify aims to achieve cash flow positive status by next year and targets a public listing within the next 2-3 years.
- Who
- Healthify, an Indian digital health and wellness startup
- What
- Shifting focus to the US market for growth and revenue
- When
- Aiming to be cash flow positive by next year and list publicly within 2-3 years
- Where
- Primarily targeting the US market, with continued operations in India
- Why
- To capitalize on the growing diet and nutrition apps market and achieve significant revenue growth
- Projected Revenue by 2027
- Double-digit millions
- Expected CAGR (2024-2030)
- 13.4%
- Target for Cash Flow Positive Status
- Next year
- Target for Public Listing
- 2-3 years
- Indian Anti-Obesity Drug Market Growth (2021-2025)
- ₹133 crore to ₹576 crore